Ledger.Open graph →
SEC Form D · filed July 12, 2018

Recida Therapeutics, Inc

Offering
$10.7M
Sold
$5.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Adrienne Graves · San Francisco, CAExecYigong Ge · Menlo Park, CAExec · DirectorDavid Socks · Seattle, WADirectorSimon Bachleda · Denver, COExecPatrick Heron · Palo Alto, CADirectorYigong Ge · Menlo Park, CAExec · DirectorDavid Socks · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗